Three Tufts scientists and their teams have received capital funding this month from the Massachusetts Life Sciences Center (MLSC) to support research ranging from drug delivery to disease detection technologies.
The grants were part of a total of $18 million to 14 recipients from the state agency, which seeks to advance life sciences research and development and innovation in the Commonwealth.
At Cummings School, the funds will help purchase essential equipment for the state-of-the-art comparative pathology and genomics core “that will advance the utility and application of infectious disease models,” said Cheryl London, V90, associate dean for research and graduate education at Cummings School and Anne Engen and Dusty Professor in Comparative Oncology.